CN110157721A - A tracer targeting plasmid of vaccinia virus Tiantan strain and preparation method thereof - Google Patents
A tracer targeting plasmid of vaccinia virus Tiantan strain and preparation method thereof Download PDFInfo
- Publication number
- CN110157721A CN110157721A CN201910012569.2A CN201910012569A CN110157721A CN 110157721 A CN110157721 A CN 110157721A CN 201910012569 A CN201910012569 A CN 201910012569A CN 110157721 A CN110157721 A CN 110157721A
- Authority
- CN
- China
- Prior art keywords
- vaccinia virus
- plasmid
- tracer
- luc
- tiantan strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013612 plasmid Substances 0.000 title claims abstract description 63
- 239000000700 radioactive tracer Substances 0.000 title claims abstract description 47
- 241000700649 Vaccinia virus Tian Tan Species 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 230000008685 targeting Effects 0.000 title abstract description 35
- 230000006801 homologous recombination Effects 0.000 claims abstract description 20
- 238000002744 homologous recombination Methods 0.000 claims abstract description 20
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 18
- 108060001084 Luciferase Proteins 0.000 claims abstract description 16
- 239000005089 Luciferase Substances 0.000 claims abstract description 16
- 108010048367 enhanced green fluorescent protein Proteins 0.000 claims abstract description 14
- 108700008625 Reporter Genes Proteins 0.000 claims abstract description 13
- 101150003725 TK gene Proteins 0.000 claims abstract description 13
- 239000003550 marker Substances 0.000 claims abstract description 12
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 9
- 239000012634 fragment Substances 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 230000029087 digestion Effects 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000012408 PCR amplification Methods 0.000 claims description 4
- 238000004925 denaturation Methods 0.000 claims description 4
- 230000036425 denaturation Effects 0.000 claims description 4
- 230000004927 fusion Effects 0.000 claims description 4
- 238000001502 gel electrophoresis Methods 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 claims description 3
- 238000000137 annealing Methods 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims description 3
- 108091008146 restriction endonucleases Proteins 0.000 claims description 3
- 229960005486 vaccine Drugs 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 230000002068 genetic effect Effects 0.000 claims 2
- 241000283690 Bos taurus Species 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000005516 engineering process Methods 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 238000004064 recycling Methods 0.000 claims 1
- 241000700618 Vaccinia virus Species 0.000 abstract description 16
- 241000700605 Viruses Species 0.000 abstract description 11
- 108020004414 DNA Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000000174 oncolytic effect Effects 0.000 description 3
- 230000006798 recombination Effects 0.000 description 3
- 238000005215 recombination Methods 0.000 description 3
- 230000029918 bioluminescence Effects 0.000 description 2
- 238000005415 bioluminescence Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102000006601 Thymidine Kinase Human genes 0.000 description 1
- 108020004440 Thymidine kinase Proteins 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000001815 biotherapy Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
本发明公开了一种痘苗病毒天坛株的示踪打靶质粒,包括痘苗病毒天坛株TK基因的上游同源重组臂VTT‑TKL和下游同源重组臂VTT‑TKR,上游同源重组臂VTT‑TKL和下游同源重组臂VTT‑TKR间插入Luciferase报告基因和EGFP绿色荧光蛋白标记基因,Luciferase报告基因和EGFP绿色荧光蛋白标记基因由启动子P7.5启动表达。本发明还公开了该痘苗病毒天坛株的示踪打靶质粒的制备方法。本发明一种痘苗病毒天坛株的示踪打靶质粒,能够靶向去除痘苗病毒天坛株中的TK基因,制备出去除TK基因的重组天坛株病毒。
The invention discloses a tracer targeting plasmid of the Tiantan strain of vaccinia virus, comprising an upstream homologous recombination arm VTT‑TKL, a downstream homologous recombination arm VTT‑TKR, and an upstream homologous recombination arm VTT‑TKL of the TK gene of the vaccinia virus Tiantan strain. The Luciferase reporter gene and EGFP green fluorescent protein marker gene are inserted between the downstream homologous recombination arm VTT-TKR, and the Luciferase reporter gene and EGFP green fluorescent protein marker gene are expressed by the promoter P7.5. The invention also discloses a preparation method of the tracer targeting plasmid of the vaccinia virus Tiantan strain. The invention discloses a tracer targeting plasmid of the Tiantan strain of vaccinia virus, capable of targeting and removing the TK gene in the Tiantan strain of the vaccinia virus, and preparing a recombinant Tiantan strain virus with the TK gene removed.
Description
技术领域technical field
本发明属于生物基因工程技术领域,涉及一种痘苗病毒天坛株的示踪打 靶质粒,本发明还涉及该痘苗病毒天坛株的示踪打靶质粒的制备方法。The invention belongs to the technical field of biological genetic engineering, and relates to a tracer targeting plasmid of the Tiantan strain of vaccinia virus, and also relates to a preparation method of the tracer targeting plasmid of the Tiantan strain of vaccinia virus.
背景技术Background technique
痘苗病毒天坛株(Vaccinia virus Tian Tan,VTT)是我国特有的疫苗株, 为了提高痘苗病毒天坛株VTT的溶瘤效力,需借助相应的打靶质粒。胸苷 激酶TK可为病毒DNA复制提供高水平的核苷酸池,正常细胞中TK水平 较低,去除病毒TK基因使病毒更倾向于在肿瘤细胞中复制,不能早在正常 细胞中复制,因此去除VTT的TK基因可提高病毒的肿瘤选择性。目前针对 痘苗病毒天坛株的打靶质粒主要用于预防传染性疾病,用于抗肿瘤应用的较少。这些打靶质粒要么缺乏示踪报告基因,要么缺乏荧光筛选标记,以此形 成的重组VTT病毒要么无法示踪,要么示踪能力较弱,要么较难筛选,因 此无法满足当前减毒溶瘤痘苗病毒研究的需要。Vaccinia virus Tian Tan (VTT) strain is a unique vaccine strain in my country. In order to improve the oncolytic efficacy of vaccinia virus Tian Tan strain VTT, the corresponding targeting plasmid is needed. Thymidine kinase TK can provide a high level of nucleotide pool for viral DNA replication, and the level of TK in normal cells is low. Removing the viral TK gene makes the virus more inclined to replicate in tumor cells and cannot replicate in normal cells earlier, so Removing the TK gene of VTT improves the tumor selectivity of the virus. At present, targeting plasmids targeting the Tiantan strain of vaccinia virus are mainly used for the prevention of infectious diseases, and are rarely used for anti-tumor applications. These targeting plasmids either lack a tracer reporter gene or a fluorescent selection marker, and the resulting recombinant VTT virus is either unable to be traced, or has a weak traceability, or is difficult to screen, so it cannot meet the requirements of the current attenuated oncolytic vaccinia virus. research needs.
发明内容Contents of the invention
本发明的目的是提供一种痘苗病毒天坛株的示踪打靶质粒,能够靶向去 除痘苗病毒天坛株TK基因,并使其携带示踪标记基因,制备出去除TK基 因的具有示踪能力的重组天坛株病毒。The purpose of the present invention is to provide a tracer targeting plasmid of vaccinia virus Tiantan strain, which can target and remove the TK gene of vaccinia virus Tiantan strain, and make it carry a tracer marker gene, and prepare a recombination with traceability that removes the TK gene Tiantan strain virus.
本发明另一个目的是提供一种痘苗病毒天坛株的示踪打靶质粒的制备 方法。Another object of the present invention is to provide a method for preparing a tracer targeting plasmid of vaccinia virus Tiantan strain.
本发明所采用的技术方案是,一种痘苗病毒天坛株的示踪打靶质粒,包 括痘苗病毒天坛株TK基因的上游同源重组臂VTT-TKL和下游同源重组臂 VTT-TKR,上游同源重组臂VTT-TKL和下游同源重组臂VTT-TKR间插入 EGFP绿色荧光蛋白标记基因,EGFP绿色荧光蛋白标记基因由启动子P7.5 启动表达。The technical solution adopted in the present invention is a tracer targeting plasmid of the Tiantan strain of vaccinia virus, including the upstream homologous recombination arm VTT-TKL and the downstream homologous recombination arm VTT-TKR of the TK gene of the vaccinia virus Tiantan strain. The EGFP green fluorescent protein marker gene was inserted between the recombination arm VTT-TKL and the downstream homologous recombination arm VTT-TKR, and the expression of the EGFP green fluorescent protein marker gene was driven by the promoter P7.5.
本发明第一种技术方案的特点还在于:The feature of the first technical solution of the present invention is also:
打靶质粒还包括Luciferase报告基因,Luciferase报告基因也位于上游 同源重组臂VTT-TKL和下游同源重组臂VTT-TKR之间,Luciferase报告基 因由启动子P7.5启动表达,打靶质粒的核苷酸序列如序列表1所示。The targeting plasmid also includes a Luciferase reporter gene. The Luciferase reporter gene is also located between the upstream homologous recombination arm VTT-TKL and the downstream homologous recombination arm VTT-TKR. The Luciferase reporter gene is expressed by the promoter P7.5, and the nucleoside of the targeting plasmid The acid sequences are shown in Sequence Table 1.
打靶质粒的出发载体pMV-VTTTK-Luc。The departure vector of the targeting plasmid is pMV-VTTTK-Luc.
本发明采用的另一种技术方案是:Another kind of technical scheme that the present invention adopts is:
一种痘苗病毒天坛株的示踪打靶质粒的制备方法,具体按照下述步骤进 行:A method for preparing a tracer targeting plasmid of vaccinia virus Tiantan strain, specifically carried out according to the following steps:
步骤1,构建荧光标记示踪基因片段E-Luc片段,E-Luc片段的核苷酸 序列如序列表2所示;Step 1, construct the fluorescent marker tracer gene fragment E-Luc fragment, the nucleotide sequence of the E-Luc fragment is as shown in Sequence Table 2;
步骤2,将所述E-Luc片段用酶切连接的方法连接至pMV-VTTTK-Luc 质粒中,得到痘苗病毒天坛株的示踪打靶质粒。In step 2, the E-Luc fragment was ligated into the pMV-VTTTK-Luc plasmid by restriction endonuclease ligation to obtain a tracer targeting plasmid of the Tiantan strain of vaccinia virus.
本发明另一种技术方案的特点还在于:The feature of another kind of technical scheme of the present invention is also in:
步骤1具体按照下述方法进行:Step 1 is specifically carried out as follows:
步骤1.1,以pEGFP-Luc质粒为模板,根据Luciferase报告基因和EGFP 绿色荧光蛋白标记基因的融合序列,设计引物;Step 1.1, using the pEGFP-Luc plasmid as a template, design primers according to the fusion sequence of the Luciferase reporter gene and the EGFP green fluorescent protein marker gene;
步骤1.2,在引物的一端添加酶切位点EcoRI,在所述引物的另一端酶 切位点XmaI,得到合成引物;Step 1.2, adding a restriction site EcoRI at one end of the primer, and a restriction site XmaI at the other end of the primer to obtain a synthetic primer;
步骤1.3,以pEGFP-Luc质粒为模板,以步骤2得到的序列为引物,经PCR扩增后,得到光标记示踪基因片段E-Luc片段。In step 1.3, the pEGFP-Luc plasmid is used as a template, and the sequence obtained in step 2 is used as a primer. After PCR amplification, the light-labeled tracer gene fragment E-Luc fragment is obtained.
步骤1.2中的合成引物为:The synthetic primers in step 1.2 are:
ELuc-F:5’-GGAATTCGCCACCATGGAAGACGCCA-3’ELuc-F: 5'-GGAATTCGCCACCATGGAAGACGCCA-3'
ELuc-R:5’-TCCCCCCGGGTTACTTGTACAGCTCGTCCATG-3。ELuc-R: 5'-TCCCCCCGGGTTACTTGTACAGCTCGTCCATG-3.
步骤1.3中,PCR反应体系为:DNA 1μl,dNTP mix(2.5mM)1μl,正向 引物(10μM)2μl,反向引物(10μM)2μl,5×PrimeSTAR buffer 10μl, PrimeSTAR HS DNA聚合酶0.5μl,加DEPC水至50μl。In step 1.3, the PCR reaction system is: DNA 1 μl, dNTP mix (2.5mM) 1 μl, forward primer (10 μM) 2 μl, reverse primer (10 μM) 2 μl, 5×PrimeSTAR buffer 10 μl, PrimeSTAR HS DNA polymerase 0.5 μl, Add DEPC water to 50 μl.
PCR反应条件为:98℃预变性30s;98℃变性10s,55-60℃退火15s, 72℃延伸1min/kb,循环30次;72℃延伸5分钟,最后置于4℃保存;The PCR reaction conditions are: pre-denaturation at 98°C for 30s; denaturation at 98°C for 10s, annealing at 55-60°C for 15s, extension at 72°C for 1min/kb, cycled 30 times; extension at 72°C for 5 minutes, and finally stored at 4°C;
PCR片段回收:PCR产物经琼脂糖凝胶电泳,切胶回收E-Luc片段。PCR fragment recovery: PCR products were subjected to agarose gel electrophoresis, and the E-Luc fragment was recovered by cutting the gel.
步骤2具体按照下述步骤进行:Step 2 is specifically carried out in accordance with the following steps:
步骤2.1,将pMV-VTTTK-Luc质粒经EcoRI/XmaI双酶切,凝胶电泳回 收大片段作为载体;Step 2.1, the pMV-VTTTK-Luc plasmid is digested with EcoRI/XmaI, and the large fragment is recovered by gel electrophoresis as a carrier;
将E-Luc片段进过EcoRI/XmaI双酶切,然后纯化回收获得连接片段;The E-Luc fragment was subjected to EcoRI/XmaI double digestion, and then purified and recovered to obtain the ligated fragment;
步骤2.2,将载体和连接片段进行连接、转化,得到痘苗病毒天坛株的 示踪打靶质粒。In step 2.2, the vector and the ligated fragment are ligated and transformed to obtain the tracer targeting plasmid of the Tiantan strain of vaccinia virus.
步骤2.2中将载体和连接片段按照分子克隆技术进行连接、转化。In step 2.2, the vector and the connected fragments are connected and transformed according to the molecular cloning technique.
本发明的有益效果是:The beneficial effects of the present invention are:
本发明一种痘苗病毒天坛株的示踪打靶质粒,能够靶向去除痘苗病毒天 坛株中的TK基因,制备出去除TK基因的具有示踪能力的重组天坛株病毒;The tracer targeting plasmid of a kind of vaccinia virus Tiantan strain of the present invention can be targeted to remove the TK gene in the vaccinia virus Tiantan strain, and prepare the recombinant Tiantan strain virus with traceability that removes the TK gene;
本发明一种痘苗病毒天坛株的示踪打靶质粒,EGFP绿色荧光蛋白标记 可用于筛选重组病毒;Luciferase报告基因可通过催化荧光素产生生物荧光, 发挥示踪功能,用于分析溶瘤VTT病毒在体内的分布情况,尤其在肿瘤中 的分布,为痘苗病毒作为载体研发活疫苗及肿瘤生物治疗提供了良好工具。A tracer targeting plasmid of the Tiantan strain of vaccinia virus of the present invention, EGFP green fluorescent protein marker can be used to screen recombinant viruses; Luciferase reporter gene can generate bioluminescence by catalyzing fluorescein, and play a tracer function, which is used to analyze oncolytic VTT virus in The distribution in the body, especially in tumors, provides a good tool for vaccinia virus as a carrier to develop live vaccines and tumor biotherapy.
附图说明Description of drawings
图1是本发明一种痘苗病毒天坛株的示踪打靶质粒的质粒图谱;Fig. 1 is the plasmid map of the tracer targeting plasmid of a kind of vaccinia virus Tiantan strain of the present invention;
图2是E-Luc片段PCR扩增产物凝胶电泳结果;Fig. 2 is the gel electrophoresis result of PCR amplification product of E-Luc fragment;
图3是载体pMV-VTTTK-Luc质粒的结构示意图;Fig. 3 is the structural representation of carrier pMV-VTTTK-Luc plasmid;
图4是本发明一种痘苗病毒天坛株的示踪打靶质粒的酶切鉴定结果;Fig. 4 is the enzyme digestion identification result of the tracer targeting plasmid of a kind of vaccinia virus Tiantan strain of the present invention;
图5-图8是本发明一种痘苗病毒天坛株的示踪打靶质粒的测序鉴定结 果。Fig. 5-Fig. 8 is the sequence identification result of the tracer targeting plasmid of a kind of vaccinia virus Tiantan strain of the present invention.
具体实施方式Detailed ways
下面结合附图和具体实施方式对本发明进行详细说明。The present invention will be described in detail below in conjunction with the accompanying drawings and specific embodiments.
本发明所使用的材料、试剂,如无特殊说明,均可从商业途径获得。The materials and reagents used in the present invention can be obtained from commercial sources unless otherwise specified.
本发明中野生痘苗病毒天坛株的基因组DNA序列为GenBank号为 AF095689.1的序列(VRL 14-FEB-2000)。痘苗病毒天坛株在西安医学院分 子病毒与病毒免疫学实验室(本实验室,下同)保藏。质粒pEGFP-Luc和 pMV-VTTTK-Luc由本实验室保藏。The genomic DNA sequence of the wild vaccinia virus Tiantan strain in the present invention is the sequence (VRL 14-FEB-2000) of GenBank number AF095689.1. The Tiantan strain of vaccinia virus was preserved in the Laboratory of Molecular Virology and Viral Immunology of Xi'an Medical College (this laboratory, the same below). Plasmids pEGFP-Luc and pMV-VTTTK-Luc are preserved by our laboratory.
一,一种痘苗病毒天坛株的示踪打靶质粒,如图1所示,包括 pMV-VTTTK-ELuc质粒,pMV-VTTTK-Luc质粒插入有痘苗病毒天坛株TK 基因的上游同源重组臂VTT-TKL和下游同源重组臂VTT-TKR,上游同源 重组臂VTT-TKL和下游同源重组臂VTT-TKR间插入EGFP绿色荧光蛋白标 记基因和Luciferase报告基因,EGFP绿色荧光蛋白标记基因和Luciferase报告基因均由痘苗病毒启动子P7.5启动表达。One, a tracer targeting plasmid of the vaccinia virus Tiantan strain, as shown in Figure 1, includes the pMV-VTTTK-ELuc plasmid, and the pMV-VTTTK-Luc plasmid is inserted into the upstream homologous recombination arm VTT- Insert EGFP green fluorescent protein marker gene and Luciferase reporter gene between TKL and downstream homologous recombination arm VTT-TKR, upstream homologous recombination arm VTT-TKL and downstream homologous recombination arm VTT-TKR, EGFP green fluorescent protein marker gene and Luciferase reporter All the genes were expressed by vaccinia virus promoter P7.5.
本发明一种痘苗病毒天坛株的示踪打靶质粒,同源臂VTT-TKL和 VTT-TKR与VTT的TK基因两侧的序列发生同源重组,形成敲除TK基因、 表达Luciferase和EGFP的重组VTT病毒。EGFP荧光标记可用于筛选重组 病毒;Luciferase通过催化荧光素产生生物荧光,发挥示踪功能以确定病毒 在体内的分布情况。A tracer targeting plasmid of the Tiantan strain of vaccinia virus of the present invention, the homologous arms VTT-TKL and VTT-TKR undergo homologous recombination with the sequences on both sides of the TK gene of VTT to form a recombination that knocks out the TK gene and expresses Luciferase and EGFP VTT virus. EGFP fluorescent labeling can be used to screen recombinant viruses; Luciferase catalyzes fluorescein to produce bioluminescence, and plays a tracing function to determine the distribution of viruses in vivo.
二,一种痘苗病毒天坛株的示踪打靶质粒的制备方法,按照下述步骤进 行:Two, a kind of preparation method of the tracer targeting plasmid of vaccinia virus Tiantan strain, carry out according to the following steps:
步骤1,构建荧光标记示踪基因片段E-Luc片段;Step 1, constructing a fluorescently labeled tracer gene fragment E-Luc fragment;
步骤1.1,以pEGFP-Luc质粒为模板,根据Luciferase和EGFP融合基 因的融合序列,设计引物;Step 1.1, using the pEGFP-Luc plasmid as a template, according to the fusion sequence of Luciferase and EGFP fusion gene, design primers;
步骤1.2,在所引物的一端添加酶切位点EcoRI,在引物的另一端酶切 位点XmaI,得到合成引物,合成引物的序列信息如下:Step 1.2, add the enzyme cutting site EcoRI at one end of the primer, and the enzyme cutting site XmaI at the other end of the primer to obtain a synthetic primer. The sequence information of the synthetic primer is as follows:
ELuc-F:5’-GGAATTCGCCACCATGGAAGACGCCA-3’(下划线之前部 分为保护碱基,下划线部分为EcoRI内切酶识别序列,其后序列为序列2的 第1-19位)ELuc-F: 5'-G GAATTC GCCACCATGGAAGACGCCA-3' (the part before the underline is the protected base, the underline part is the EcoRI endonuclease recognition sequence, and the sequence after that is the 1-19th position of sequence 2)
ELuc-R:5’-TCCCCCCGGGTTACTTGTACAGCTCGTCCATG-3’(下划 线之前部分为保护碱基,下划线部分为XmaI内切酶识别序列,其后序列为 序列2的第2376-2397位的反向互补序列);ELuc-R: 5'-TCCC CCCGGG TTACTTGTACAGCTCGTCCATG-3' (the part before the underline is the protective base, the underline part is the XmaI endonuclease recognition sequence, and the sequence thereafter is the reverse complementary sequence of the 2376-2397th position of sequence 2) ;
步骤1.3,以pEGFP-Luc质粒为模板,经PCR扩增后,得到光标记示踪 基因片段E-Luc片段,E-Luc片段的基因序列见序列表2。In step 1.3, the pEGFP-Luc plasmid is used as a template, and after PCR amplification, the light-labeled tracer gene fragment E-Luc fragment is obtained, and the gene sequence of the E-Luc fragment is shown in Sequence Table 2.
PCR反应体系为:DNA 1μl,dNTP mix(2.5mM)1μl,正向引物(10μM) 2μl,反向引物(10μM)2μl,5×PrimeSTAR buffer 10μl,PrimeSTAR HS DNA 聚合酶0.5μl,加DEPC水至50μl。The PCR reaction system is: DNA 1μl, dNTP mix (2.5mM) 1μl, forward primer (10μM) 2μl, reverse primer (10μM) 2μl, 5×PrimeSTAR buffer 10μl, PrimeSTAR HS DNA polymerase 0.5μl, add DEPC water to 50 μl.
PCR反应条件为:98℃预变性30s;98℃变性10s,60℃退火15s,72℃ 延伸1min/kb,循环30次;72℃延伸5分钟,最后置于4℃保存;The PCR reaction conditions are: pre-denaturation at 98°C for 30s; denaturation at 98°C for 10s, annealing at 60°C for 15s, extension at 72°C for 1min/kb, and 30 cycles; extension at 72°C for 5 minutes, and finally stored at 4°C;
PCR片段回收:PCR产物经琼脂糖凝胶电泳,带酶切位点的E-Luc为2414bp,电泳结果见图2,切胶回收目的片段。PCR fragment recovery: The PCR product was subjected to agarose gel electrophoresis, and the E-Luc with the enzyme cutting site was 2414bp. The electrophoresis result is shown in Figure 2, and the target fragment was recovered by cutting the gel.
步骤2,将E-Luc片段酶切连接的方法连接至pMV-VTTTK-Luc质粒中, 得到痘苗病毒天坛株的示踪打靶质粒:Step 2. Ligate the E-Luc fragment into the pMV-VTTTK-Luc plasmid by enzyme-cut ligation to obtain the tracer targeting plasmid of the vaccinia virus Tiantan strain:
步骤2.1,将如图3所示的pMV-VTTTK-Luc质粒经EcoRI/XmaI双酶切, 凝胶电泳回收4197bp片段得到载体;In step 2.1, the pMV-VTTTK-Luc plasmid shown in Figure 3 was digested with EcoRI/XmaI, and the 4197bp fragment was recovered by gel electrophoresis to obtain the vector;
将E-Luc片段进过EcoRI/XmaI双酶切,纯化回收2403bp片段,得到连 接片段;The E-Luc fragment was subjected to EcoRI/XmaI double digestion, and the 2403bp fragment was purified and recovered to obtain the ligated fragment;
步骤2.2,将载体和连接片段经分子克隆技术进行连接、转化,得到痘 苗病毒天坛株的示踪打靶质粒。In step 2.2, the vector and the connecting fragment are ligated and transformed by molecular cloning techniques to obtain the tracer targeting plasmid of the Tiantan strain of vaccinia virus.
将本实施例得到的痘苗病毒天坛株的示踪打靶质粒进行酶切鉴定,鉴定 结果如图4所示,痘苗病毒天坛株的示踪打靶质粒经EcoRI/XmaI双酶切产 生4197bp片段和2403bp,与预期片段大小一致;The tracer targeting plasmid of the vaccinia virus Tiantan strain obtained in this example was digested and identified, and the identification results are shown in Figure 4. The tracer targeting plasmid of the vaccinia virus Tiantan strain was digested with EcoRI/XmaI to produce a 4197bp fragment and a 2403bp fragment. Consistent with the expected fragment size;
将本实施例得到的痘苗病毒天坛株的示踪打靶质粒进行基因序 列测定,如图5、图6、图7和图8所示,从图5、图6、图7和图8 中可知:显示基因序列没有发生变化,插入位置正确;因此,痘苗病 毒天坛株的示踪打靶质粒构建成功。The tracer targeting plasmid of the vaccinia virus Tiantan strain obtained in this embodiment is subjected to gene sequence determination, as shown in Fig. 5, Fig. 6, Fig. 7 and Fig. 8, as can be seen from Fig. 5, Fig. 6, Fig. 7 and Fig. 8: It showed that the gene sequence did not change, and the insertion position was correct; therefore, the tracer targeting plasmid of the vaccinia virus Tiantan strain was successfully constructed.
SEQUENCE LISTINGSEQUENCE LISTING
<110> 西安医学院<110> Xi'an Medical College
<120> 一种痘苗病毒天坛株的示踪打靶质粒及其制备方法<120> A tracer targeting plasmid of vaccinia virus Tiantan strain and its preparation method
<160> 2<160> 2
<210> 1<210> 1
<211> 6600<211> 6600
<212> DNA<212> DNA
<213> 人工序列<213> Artificial sequence
<400> 1<400> 1
aaaaataaac aaataggggt tccgcgcaca tttccccgaa aagtgccacc tgacgtctaa 60aaaaataaac aaataggggt tccgcgcaca tttccccgaa aagtgccacc tgacgtctaa 60
gaaaccatta ttatcatgac attaacctat aaaaataggc gtatcacgag gccctttcgt 120gaaaccatta ttatcatgac attaacctat aaaaataggc gtatcacgag gccctttcgt 120
tgtaaaacga cggccagtcg aaccacgcaa tgcgtctcga tccgcagtgt cttgcgtctc 180tgtaaaacga cggccagtcg aaccacgcaa tgcgtctcga tccgcagtgt cttgcgtctc 180
tttactgcag acagatattc cgacaaagga ttgattacta taaatggaga atgttcctaa 240tttactgcag acagatattc cgacaaagga ttgattacta taaatggaga atgttcctaa 240
tgtatacttt aatcctgtgt ttatagagcc cacgtttaaa cattctttat taagtgttta 300tgtatacttt aatcctgtgt ttatagagcc cacgtttaaa cattctttat taagtgttta 300
taaacacaga ttaatagttt tatttgaagt attcattgta ttcattctaa tatatgtatt 360taaacacaga ttaatagttttatttgaagt attcattgta ttcattctaa tatatgtatt 360
ttttagatct gaattaaata tgttcttcat gcctaaacga aaaatacccg atcctattga 420ttttagatct gaattaaata tgttcttcat gcctaaacga aaaatacccg atcctattga 420
tagattacga cgtgctaatc tagcgtgtga agacgataaa ttaatgatct atggattacc 480tagattacga cgtgctaatc tagcgtgtga agacgataaa ttaatgatct atggattacc 480
atggatgaca actcaaacat ctgcgttatc aataaatagt aaaccgatag tgtataaaga 540atggatgaca actcaaacat ctgcgttatc aataaatagt aaaccgatag tgtataaaga 540
ttgtgcaaag cttttgcgat caataaatgg atcacaacca gtatctctta acgatgttct 600ttgtgcaaag cttttgcgat caataaatgg atcacaacca gtatctctta acgatgttct 600
tcgcagatga tgattcattt tttaagtatt tggctagtca agatgatgaa tcttcattat 660tcgcagatga tgattcattt tttaagtatt tggctagtca agatgatgaa tcttcattat 660
ctgatatatt gcaaatcact caatatctag actttctgtt attattattg atccaatcaa 720ctgatatatt gcaaatcact caatatctag actttctgtt attattattg atccaatcaa 720
aaaataaatt agaagccgtg ggtcattgtt atgaatctct ttcagaggaa tacagacaat 780aaaataaatt agaagccgtg ggtcattgtt atgaatctct ttcagaggaa tacagacaat 780
tgacaaaatt cacagactct caagatttta aaaaactgtt taacaaggtc cctattgtta 840tgacaaaatt cacagactct caagatttta aaaaactgtt taacaaggtc cctattgtta 840
cagatggaag ggtcaaactt aataaaggat atttgttcga ctttgtgatt agtttgatgc 900cagatggaag ggtcaaactt aataaaggat atttgttcga ctttgtgatt agtttgatgc 900
gattcaaaaa agaatcctct ctagctacca ccgcaataga tcctattaga tacatagatc 960gattcaaaaa agaatcctct ctagctacca ccgcaataga tcctattaga tacatagatc 960
ctcgtcgcga tatcgcattt tctaacgtga tggatatatt aaagtcgaat aaagtgaaca 1020ctcgtcgcga tatcgcattt tctaacgtga tggatatatt aaagtcgaat aaagtgaaca 1020
ataattaatt ctttattgtc atcatgaacg gcggacatat tcagttgatg tcgacaagct 1080ataattaatt ctttattgtc atcatgaacg gcggacatat tcagttgatg tcgacaagct 1080
tcaactgtcc atgggcccgc ggccgctcga gcatctggta atttatagca tagaaaaaaa 1140tcaactgtcc atggcccgc ggccgctcga gcatctggta atttatagca tagaaaaaaa 1140
caaaatgaaa ttctactata tttttacata catatattct aaatatgaaa gtggtgattg 1200caaaatgaaa ttctactata tttttacata catatattct aaatatgaaa gtggtgattg 1200
tgactagcgt agcatcgctc atctatatac tatatagtaa taccaataga gctcaagact 1260tgactagcgt agcatcgctc atctatatac tatatagtaa taccaataga gctcaagact 1260
acgactagta aactgataca atctcttata tgtgggtaat gttctcgatg tcgatagcca 1320acgactagta aactgataca atctcttata tgtgggtaat gttctcgatg tcgatagcca 1320
tatgcccggt agttgcgata tacataaact gatcactaat tccaaaccca cccgcttttt 1380tatgcccggt agttgcgata tacataaact gatcactaat tccaaaccca cccgcttttt 1380
atagtaagtt tttcacccat aaataataaa tacaatggaa ttcgccacca tggaagacgc 1440atagtaagtt tttcacccat aaataataaa tacaatggaa ttcgccacca tggaagacgc 1440
caaaaacata aagaaaggcc cggcgccatt ctatccgctg gaagatggaa ccgctggaga 1500caaaaacata aagaaaggcc cggcgccatt ctatccgctg gaagatggaa ccgctggaga 1500
gcaactgcat aaggctatga agagatacgc cctggttcct ggaacaattg cttttacaga 1560gcaactgcat aaggctatga agagatacgc cctggttcct ggaacaattg cttttacaga 1560
tgcacatatc gaggtggaca tcacttacgc tgagtacttc gaaatgtccg ttcggttggc 1620tgcacatatc gaggtggaca tcacttacgc tgagtacttc gaaatgtccg ttcggttggc 1620
agaagctatg aaacgatatg ggctgaatac aaatcacaga atcgtcgtat gcagtgaaaa 1680agaagctatg aaacgatatg ggctgaatac aaatcacaga atcgtcgtat gcagtgaaaa 1680
ctctcttcaa ttctttatgc cggtgttggg cgcgttattt atcggagttg cagttgcgcc 1740ctctcttcaa ttctttatgc cggtgttggg cgcgttattt atcggagttg cagttgcgcc 1740
cgcgaacgac atttataatg aacgtgaatt gctcaacagt atgggcattt cgcagcctac 1800cgcgaacgac atttataatg aacgtgaatt gctcaacagt atgggcattt cgcagcctac 1800
cgtggtgttc gtttccaaaa aggggttgca aaaaattttg aacgtgcaaa aaaagctccc 1860cgtggtgttc gtttccaaaa aggggttgca aaaaattttg aacgtgcaaa aaaagctccc 1860
aatcatccaa aaaattatta tcatggattc taaaacggat taccagggat ttcagtcgat 1920aatcatccaa aaaattatta tcatggattc taaaacggat taccagggat ttcagtcgat 1920
gtacacgttc gtcacatctc atctacctcc cggttttaat gaatacgatt ttgtgccaga 1980gtacacgttc gtcacatctc atctacctcc cggttttaat gaatacgatt ttgtgccaga 1980
gtccttcgat agggacaaga caattgcact gatcatgaac tcctctggat ctactggtct 2040gtccttcgat agggacaaga caattgcact gatcatgaac tcctctggat ctactggtct 2040
gcctaaaggt gtcgctctgc ctcatagaac tgcctgcgtg agattctcgc atgccagaga 2100gcctaaaggt gtcgctctgc ctcatagaac tgcctgcgtg agattctcgc atgccagaga 2100
tcctattttt ggcaatcaaa tcattccgga tactgcgatt ttaagtgttg ttccattcca 2160tcctattttt ggcaatcaaa tcattccgga tactgcgatt ttaagtgttg ttccattcca 2160
tcacggtttt ggaatgttta ctacactcgg atatttgata tgtggatttc gagtcgtctt 2220tcacggtttt ggaatgttta ctacactcgg atatttgata tgtggatttc gagtcgtctt 2220
aatgtataga tttgaagaag agctgtttct gaggagcctt caggattaca agattcaaag 2280aatgtataga tttgaagaag agctgtttct gaggagcctt caggattaca agattcaaag 2280
tgcgctgctg gtgccaaccc tattctcctt cttcgccaaa agcactctga ttgacaaata 2340tgcgctgctg gtgccaaccc tattctcctt cttcgccaaa agcactctga ttgacaaata 2340
cgatttatct aatttacacg aaattgcttc tggtggcgct cccctctcta aggaagtcgg 2400cgattattct aatttacacg aaattgcttc tggtggcgct cccctctcta aggaagtcgg 2400
ggaagcggtt gccaagaggt tccatctgcc aggtatcagg caaggatatg ggctcactga 2460ggaagcggtt gccaagaggt tccatctgcc aggtatcagg caaggatatg ggctcactga 2460
gactacatca gctattctga ttacacccga gggggatgat aaaccgggcg cggtcggtaa 2520gactacatca gctattctga ttacacccga gggggatgat aaaccgggcg cggtcggtaa 2520
agttgttcca ttttttgaag cgaaggttgt ggatctggat accgggaaaa cgctgggcgt 2580agttgttcca ttttttgaag cgaaggttgt ggatctggat accgggaaaa cgctgggcgt 2580
taatcaaaga ggcgaactgt gtgtgagagg tcctatgatt atgtccggtt atgtaaacaa 2640taatcaaaga ggcgaactgt gtgtgagagg tcctatgatt atgtccggtt atgtaaacaa 2640
tccggaagcg accaacgcct tgattgacaa ggatggatgg ctacattctg gagacatagc 2700tccggaagcg accaacgcct tgattgacaa ggatggatgg ctacattctg gagacatagc 2700
ttactgggac gaagacgaac acttcttcat cgttgaccgc ctgaagtctc tgattaagta 2760ttactgggac gaagacgaac acttcttcat cgttgaccgc ctgaagtctc tgattaagta 2760
caaaggctat caggtggctc ccgctgaatt ggaatccatc ttgctccaac accccaacat 2820caaaggctat caggtggctc ccgctgaatt ggaatccatc ttgctccaac accccaacat 2820
cttcgacgca ggtgtcgcag gtcttcccga cgatgacgcc ggtgaacttc ccgccgccgt 2880cttcgacgca ggtgtcgcag gtcttcccga cgatgacgcc ggtgaacttc ccgccgccgt 2880
tgttgttttg gagcacggaa agacgatgac ggaaaaagag atcgtggatt acgtcgccag 2940tgttgttttg gagcacggaa agacgatgac ggaaaaagag atcgtggatt acgtcgccag 2940
tcaagtaaca accgcgaaaa agttgcgcgg aggagttgtg tttgtggacg aagtaccgaa 3000tcaagtaaca accgcgaaaa agttgcgcgg aggagttgtg tttgtggacg aagtaccgaa 3000
aggtcttacc ggaaaactcg acgcaagaaa aatcagagag atcctcataa aggccaagaa 3060aggtcttacc ggaaaactcg acgcaagaaa aatcagagag atcctcataa aggccaagaa 3060
gggcggaaag atcgccgtgc gggatccacc ggtcgccacc atggtgagca agggcgagga 3120gggcggaaag atcgccgtgc gggatccacc ggtcgccacc atggtgagca agggcgagga 3120
gctgttcacc ggggtggtgc ccatcctggt cgagctggac ggcgacgtaa acggccacaa 3180gctgttcacc gggtggtgc ccatcctggt cgagctggac ggcgacgtaa acggccacaa 3180
gttcagcgtg tccggcgagg gcgagggcga tgccacctac ggcaagctga ccctgaagtt 3240gttcagcgtg tccggcgagg gcgagggcga tgccacctac ggcaagctga ccctgaagtt 3240
catctgcacc accggcaagc tgcccgtgcc ctggcccacc ctcgtgacca ccctgaccta 3300catctgcacc accggcaagc tgcccgtgcc ctggcccacc ctcgtgacca ccctgaccta 3300
cggcgtgcag tgcttcagcc gctaccccga ccacatgaag cagcacgact tcttcaagtc 3360cggcgtgcag tgcttcagcc gctaccccga ccacatgaag cagcacgact tcttcaagtc 3360
cgccatgccc gaaggctacg tccaggagcg caccatcttc ttcaaggacg acggcaacta 3420cgccatgccc gaaggctacg tccaggagcg caccatcttc ttcaaggacg acggcaacta 3420
caagacccgc gccgaggtga agttcgaggg cgacaccctg gtgaaccgca tcgagctgaa 3480caagacccgc gccgaggtga agttcgaggg cgacaccctg gtgaaccgca tcgagctgaa 3480
gggcatcgac ttcaaggagg acggcaacat cctggggcac aagctggagt acaactacaa 3540gggcatcgac ttcaaggagg acggcaacat cctggggcac aagctggagt acaactacaa 3540
cagccacaac gtctatatca tggccgacaa gcagaagaac ggcatcaagg tgaacttcaa 3600cagccacaac gtctatatca tggccgacaa gcagaagaac ggcatcaagg tgaacttcaa 3600
gatccgccac aacatcgagg acggcagcgt gcagctcgcc gaccactacc agcagaacac 3660gatccgccac aacatcgagg acggcagcgt gcagctcgcc gaccactacc agcagaacac 3660
ccccatcggc gacggccccg tgctgctgcc cgacaaccac tacctgagca cccagtccgc 3720ccccatcggc gacggccccg tgctgctgcc cgacaaccac tacctgagca cccagtccgc 3720
cctgagcaaa gaccccaacg agaagcgcga tcacatggtc ctgctggagt tcgtgaccgc 3780cctgagcaaa gaccccaacg agaagcgcga tcacatggtc ctgctggagt tcgtgaccgc 3780
cgccgggatc actctcggca tggacgagct gtacaagtaa cccgggatcc ggcttccttt 3840cgccgggatc actctcggca tggacgagct gtacaagtaa cccgggatcc ggcttccttt 3840
tctaaacgat tgggtgagga aaccgagata gaaataatag gaggtaatga tatgtatcaa 3900tctaaacgat tgggtgagga aaccgagata gaaataatag gaggtaatga tatgtatcaa 3900
tcggtgtgta gaaagtgtta catcgactca taatattata ttttttatct aaaaaactaa 3960tcggtgtgta gaaagtgtta catcgactca taatattata ttttttatct aaaaaactaa 3960
aaataaacat tgattaaatt ttaatataat acttaaaaat ggatgttgtg tcgttagata 4020aaataaacat tgattaaatt ttaatataat acttaaaaat ggatgttgtg tcgttagata 4020
aaccgtttat gtattttgag gaaattgata atgagttaga ttacgaacca gaaagtgcaa 4080aaccgtttat gtattttgag gaaattgata atgagttaga ttacgaacca gaaagtgcaa 4080
atgaggtcgc aaaaaaactg ccgtatcaag gacagttaaa actattacta ggagaattat 4140atgaggtcgc aaaaaaactg ccgtatcaag gacagttaaa actattacta ggagaattat 4140
tttttcttag taagttacag cgacacggta tattagatgg tgccaccgta gtgtatatag 4200tttttcttag taagttacag cgacacggta tattatagatgg tgccaccgta gtgtatatag 4200
gatctgctcc cggtacacat atacgttatt tgagagatca tttctataat ttaggagtga 4260gatctgctcc cggtacacat atacgttatt tgagagatca tttctataat ttaggagtga 4260
tcatcaaatg gatgctaatt gacggccgcc atcatgatcc tattttaaat ggattgcgtg 4320tcatcaaatg gatgctaatt gacggccgcc atcatgatcc tattttaaat ggattgcgtg 4320
atgtgactct agtgactcgg ttcgttgatg aggaatatct acgatccatc aaaaaacaac 4380atgtgactct agtgactcgg ttcgttgatg aggaatatct acgatccatc aaaaaacaac 4380
tgcatccttc taagattatt ttaatttctg atgtgagatc caaacgagga ggaaatgaac 4440tgcatccttc taagattatt ttaatttctg atgtgagatc caaacgagga ggaaatgaac 4440
ctagtacggc ggatttacta agtaattacg ctctacaaaa tgtcatgatt agtattttaa 4500ctagtacggc ggatttacta agtaattacg ctctacaaaa tgtcatgatt agtattttaa 4500
accccgtggc atctagtctt aaatggagat gcccgtttcc agatcaatgg atcaaggact 4560accccgtggc atctagtctt aaatggagat gcccgtttcc agatcaatgg atcaaggact 4560
tttatatccc acacggtaat aaaatgttac aaccttttgc tccttcatat tcagctgaaa 4620tttatatccc acacggtaat aaaatgttac aaccttttgc tccttcatat tcagctgaaa 4620
tgagattatt aagtatttat accggtgaga acatgagact gactcggtac ctaaagagac 4680tgagattatt aagtatttat accggtgaga acatgagact gactcggtac ctaaagagac 4680
ggagtcactg ccaaccgaga cggtcatagc tgtttcctgt gtgccgcttc ctcgctcact 4740ggagtcactg ccaaccgaga cggtcatagc tgtttcctgt gtgccgcttc ctcgctcact 4740
gactcgctgc gctcggtcgt tcggctgcgg cgagcggtat cagctcactc aaaggcggta 4800gactcgctgc gctcggtcgt tcggctgcgg cgagcggtat cagctcactc aaaggcggta 4800
atacggttac ccacagaatc aggggataac gcaggaaaga acatgtgagc aaaaggccag 4860atacggttac ccacagaatc aggggataac gcaggaaaga acatgtgagc aaaaggccag 4860
caaaaggcca ggaaccgtaa aaaggccgcg ttgctggcgt ttttccatag gctccgcccc 4920caaaaggcca ggaaccgtaa aaaggccgcg ttgctggcgt ttttccatag gctccgcccc 4920
cctgacgagc atcacaaaaa tcgacgctca agtcagaggt ggcgaaaccc gacaggacta 4980cctgacgagc atcacaaaaa tcgacgctca agtcagaggt ggcgaaaccc gacaggacta 4980
taaagatacc aggcgtttcc ccctggaagc tccctcgtgc gctctcctgt tccgaccctg 5040taaagatacc aggcgtttcc ccctggaagc tccctcgtgc gctctcctgt tccgaccctg 5040
ccgcttaccg gatacctgtc cgcctttctc ccttcgggaa gcgtggcgct ttctcatagc 5100ccgcttaccg gatacctgtc cgcctttctc ccttcgggaa gcgtggcgct ttctcatagc 5100
tcacgctgta ggtatctcag ttcggtgtag gtcgttcgct ccaagctggg ctgtgtgcac 5160tcacgctgta ggtatctcag ttcggtgtag gtcgttcgct ccaagctggg ctgtgtgcac 5160
gaaccccccg ttcagcccga ccgctgcgcc ttatccggta actatcgtct tgagtccaac 5220gaaccccccg ttcagcccga ccgctgcgcc ttatccggta actatcgtct tgagtccaac 5220
ccggtaagac acgacttatc gccactggca gcagccactg gtaacaggat tagcagagcg 5280ccggtaagac acgacttatc gccactggca gcagccactg gtaacaggat tagcagagcg 5280
aggtatgtag gcggtgctac agagttcttg aagtggtggc ctaactacgg ctacactaga 5340aggtatgtag gcggtgctac agagttcttg aagtggtggc ctaactacgg ctacactaga 5340
aggacagtat ttggtatctg cgctctgctg aagccagtta ccttcggaaa aagagttggt 5400aggacagtat ttggtatctg cgctctgctg aagccagtta ccttcggaaa aagagttggt 5400
agctcttgat ccggcaaaca aaccaccgct ggtagcggtg gtttttttgt ttgcaagcag 5460agctcttgat ccggcaaaca aaccaccgct ggtagcggtg gtttttttgt ttgcaagcag 5460
cagattacgc gcagaaaaaa aggatctcaa gaagatcctt tgatcttttc tacggggtct 5520cagattacgc gcagaaaaaa aggatctcaa gaagatcctt tgatcttttc tacggggtct 5520
gacgctcagt ggaacgaaaa ctcacgttaa gggattttgg tcatgagatt atcaaaaagg 5580gacgctcagt ggaacgaaaa ctcacgttaa gggattttgg tcatgagatt atcaaaaagg 5580
atcttcacct agatcctttt aaattaaaaa tgaagtttta aatcaatcta aagtatatat 5640atcttcacct agatcctttt aaattaaaaa tgaagtttta aatcaatcta aagtatatat 5640
gagtaaactt ggtctgacag ttaccaatgc ttaatcagtg aggcacctat ctcagcgatc 5700gagtaaactt ggtctgacag ttaccaatgc ttaatcagtg aggcacctat ctcagcgatc 5700
tgtctatttc gttcatccat agttgcctga ctccccgtcg tgtagataac tacgatacgg 5760tgtctatttc gttcatccat agttgcctga ctccccgtcg tgtagataac tacgatacgg 5760
gagggcttac catctggccc cagtgctgca ataataccgc gggacccacg ctcaccggct 5820gagggcttac catctggccc cagtgctgca ataataccgc gggacccacg ctcaccggct 5820
ccagatttat cagcaataaa ccagccagcc ggaagggccg agcgcagaag tggtcctgca 5880ccagatttat cagcaataaa ccagccagcc ggaagggccg agcgcagaag tggtcctgca 5880
actttatccg cctccatcca gtctattaat tgttgccggg aagctagagt aagtagttcg 5940actttatccg cctccatcca gtctattaat tgttgccggg aagctagagt aagtagttcg 5940
ccagttaata gtttgcgcaa cgttgttgcc atcgctacag gcatcgtggt atcacgctcg 6000ccagttaata gtttgcgcaa cgttgttgcc atcgctacag gcatcgtggt atcacgctcg 6000
tcgtttggta tggcttcatt cagctccggt tcccaacgat caaggcgagt tacatgatcc 6060tcgtttggta tggcttcatt cagctccggt tcccaacgat caaggcgagt tacatgatcc 6060
cccatgttgc gcaaaaaagc ggttagctcc ttcggtcctc cgatcgttgt cagaagtaag 6120cccatgttgc gcaaaaaagc ggttagctcc ttcggtcctc cgatcgttgt cagaagtaag 6120
ttggccgccg tgttatcact catggttatg gcagcactac ataattctct tactgtcatg 6180ttggccgccg tgttatcact catggttatg gcagcactac ataattctct tactgtcatg 6180
ccatccgtaa gatgcttttc tgtgactggt gagtactcaa ccaagtcatt ctgagaatag 6240ccatccgtaa gatgcttttc tgtgactggt gagtactcaa ccaagtcatt ctgagaatag 6240
tgtatgcggc gaccgagttg ctcttgcccg gcgtcaatac gggataatac cgcgccacat 6300tgtatgcggc gaccgagttg ctcttgcccg gcgtcaatac gggataatac cgcgccacat 6300
agcagaactt taaaagtgct catcattgga aaacgttctt cggggcgaaa actctcaagg 6360agcagaactt taaaagtgct catcattgga aaacgttctt cggggcgaaa actctcaagg 6360
atcttaccgc tgttgagatc cagttcgatg taacccactc gtgcacccaa ctgatcttca 6420atcttaccgc tgttgagatc cagttcgatg taacccactc gtgcacccaa ctgatcttca 6420
gcatctttta ctttcaccag cgtttctggg tgagcaaaaa caggaaggca aaatgccgca 6480gcatctttta ctttcaccag cgtttctggg tgagcaaaaa caggaaggca aaatgccgca 6480
aaaaagggaa taagggcgac acggaaatgt tgaatactca tactcttcct ttttcaatat 6540aaaaagggaa taagggcgac acggaaatgt tgaatactca tactcttcct ttttcaatat 6540
tattgaagca tttatcaggg ttattgtctc atgagcggat acatatttga atgtatttag 6600tattgaagca tttatcaggg ttatgtctc atgagcggat acatatttga atgtatttag 6600
<210> 2<210> 2
<211> 2397<211> 2397
<212> DNA<212> DNA
<213> 人工序列<213> Artificial sequence
<400> 2<400> 2
gccaccatgg aagacgccaa aaacataaag aaaggcccgg cgccattcta tccgctggaa 60gccaccatgg aagacgccaa aaacataaag aaaggcccgg cgccaattcta tccgctggaa 60
gatggaaccg ctggagagca actgcataag gctatgaaga gatacgccct ggttcctgga 120gatggaaccg ctggagagca actgcataag gctatgaaga gatacgccct ggttcctgga 120
acaattgctt ttacagatgc acatatcgag gtggacatca cttacgctga gtacttcgaa 180acaattgctt ttacagatgc acatatcgag gtggacatca cttacgctga gtacttcgaa 180
atgtccgttc ggttggcaga agctatgaaa cgatatgggc tgaatacaaa tcacagaatc 240atgtccgttc ggttggcaga agctatgaaa cgatatgggc tgaatacaaa tcacagaatc 240
gtcgtatgca gtgaaaactc tcttcaattc tttatgccgg tgttgggcgc gttatttatc 300gtcgtatgca gtgaaaactc tcttcaattc tttatgccgg tgttgggcgc gttatttatc 300
ggagttgcag ttgcgcccgc gaacgacatt tataatgaac gtgaattgct caacagtatg 360ggagttgcag ttgcgcccgc gaacgacatt tataatgaac gtgaattgct caacagtatg 360
ggcatttcgc agcctaccgt ggtgttcgtt tccaaaaagg ggttgcaaaa aattttgaac 420ggcatttcgc agcctaccgt ggtgttcgtt tccaaaaagg ggttgcaaaa aattttgaac 420
gtgcaaaaaa agctcccaat catccaaaaa attattatca tggattctaa aacggattac 480gtgcaaaaaa agctcccaat catccaaaaa attattatca tggattctaa aacggattac 480
cagggatttc agtcgatgta cacgttcgtc acatctcatc tacctcccgg ttttaatgaa 540cagggatttc agtcgatgta cacgttcgtc acatctcatc tacctcccgg ttttaatgaa 540
tacgattttg tgccagagtc cttcgatagg gacaagacaa ttgcactgat catgaactcc 600tacgattttg tgccagagtc cttcgatagg gacaagacaa ttgcactgat catgaactcc 600
tctggatcta ctggtctgcc taaaggtgtc gctctgcctc atagaactgc ctgcgtgaga 660tctggatcta ctggtctgcc taaaggtgtc gctctgcctc atagaactgc ctgcgtgaga 660
ttctcgcatg ccagagatcc tatttttggc aatcaaatca ttccggatac tgcgatttta 720ttctcgcatg ccagagatcc tatttttggc aatcaaatca ttccggatac tgcgatttta 720
agtgttgttc cattccatca cggttttgga atgtttacta cactcggata tttgatatgt 780agtgttgttc cattccatca cggttttgga atgtttacta cactcggata tttgatatgt 780
ggatttcgag tcgtcttaat gtatagattt gaagaagagc tgtttctgag gagccttcag 840ggatttcgag tcgtcttaat gtatagattt gaagaagagc tgtttctgag gagccttcag 840
gattacaaga ttcaaagtgc gctgctggtg ccaaccctat tctccttctt cgccaaaagc 900gattacaaga ttcaaagtgc gctgctggtg ccaaccctat tctccttctt cgccaaaagc 900
actctgattg acaaatacga tttatctaat ttacacgaaa ttgcttctgg tggcgctccc 960actctgattg acaaatacga tttatctaat ttacacgaaa ttgcttctgg tggcgctccc 960
ctctctaagg aagtcgggga agcggttgcc aagaggttcc atctgccagg tatcaggcaa 1020ctctctaagg aagtcgggga agcggttgcc aagaggttcc atctgccagg tatcaggcaa 1020
ggatatgggc tcactgagac tacatcagct attctgatta cacccgaggg ggatgataaa 1080ggatatgggc tcactgagac tacatcagct attctgatta cacccgaggg ggatgataaa 1080
ccgggcgcgg tcggtaaagt tgttccattt tttgaagcga aggttgtgga tctggatacc 1140ccgggcgcgg tcggtaaagt tgttccattt tttgaagcga aggttgtgga tctggatacc 1140
gggaaaacgc tgggcgttaa tcaaagaggc gaactgtgtg tgagaggtcc tatgattatg 1200gggaaaacgc tgggcgttaa tcaaagaggc gaactgtgtg tgagaggtcc tatgattatg 1200
tccggttatg taaacaatcc ggaagcgacc aacgccttga ttgacaagga tggatggcta 1260tccggttatg taaacaatcc ggaagcgacc aacgccttga ttgacaagga tggatggcta 1260
cattctggag acatagctta ctgggacgaa gacgaacact tcttcatcgt tgaccgcctg 1320cattctggag acatagctta ctgggacgaa gacgaacact tcttcatcgt tgaccgcctg 1320
aagtctctga ttaagtacaa aggctatcag gtggctcccg ctgaattgga atccatcttg 1380aagtctctga ttaagtacaa aggctatcag gtggctcccg ctgaattgga atccatcttg 1380
ctccaacacc ccaacatctt cgacgcaggt gtcgcaggtc ttcccgacga tgacgccggt 1440ctccaacaccc ccaacatctt cgacgcaggt gtcgcaggtc ttcccgacga tgacgccggt 1440
gaacttcccg ccgccgttgt tgttttggag cacggaaaga cgatgacgga aaaagagatc 1500gaacttcccg ccgccgttgt tgttttggag cacggaaaga cgatgacgga aaaagagatc 1500
gtggattacg tcgccagtca agtaacaacc gcgaaaaagt tgcgcggagg agttgtgttt 1560gtggattacg tcgccagtca agtaacaacc gcgaaaaagt tgcgcggagg agttgtgttt 1560
gtggacgaag taccgaaagg tcttaccgga aaactcgacg caagaaaaat cagagagatc 1620gtggacgaag taccgaaagg tcttaccgga aaactcgacg caagaaaaat cagagagatc 1620
ctcataaagg ccaagaaggg cggaaagatc gccgtgcggg atccaccggt cgccaccatg 1680ctcataaagg ccaagaaggg cggaaagatc gccgtgcggg atccaccggt cgccaccatg 1680
gtgagcaagg gcgaggagct gttcaccggg gtggtgccca tcctggtcga gctggacggc 1740gtgagcaagg gcgaggagct gttcaccggg gtggtgccca tcctggtcga gctggacggc 1740
gacgtaaacg gccacaagtt cagcgtgtcc ggcgagggcg agggcgatgc cacctacggc 1800gacgtaaacg gccacaagtt cagcgtgtcc ggcgagggcg agggcgatgc cacctacggc 1800
aagctgaccc tgaagttcat ctgcaccacc ggcaagctgc ccgtgccctg gcccaccctc 1860aagctgaccc tgaagttcat ctgcaccacc ggcaagctgc ccgtgccctg gcccaccctc 1860
gtgaccaccc tgacctacgg cgtgcagtgc ttcagccgct accccgacca catgaagcag 1920gtgaccaccc tgacctacgg cgtgcagtgc ttcagccgct accccgacca catgaagcag 1920
cacgacttct tcaagtccgc catgcccgaa ggctacgtcc aggagcgcac catcttcttc 1980cacgacttct tcaagtccgc catgcccgaa ggctacgtcc aggagcgcac catcttcttc 1980
aaggacgacg gcaactacaa gacccgcgcc gaggtgaagt tcgagggcga caccctggtg 2040aaggacgacg gcaactacaa gacccgcgcc gaggtgaagt tcgagggcga caccctggtg 2040
aaccgcatcg agctgaaggg catcgacttc aaggaggacg gcaacatcct ggggcacaag 2100aaccgcatcg agctgaaggg catcgacttc aaggaggacg gcaacatcct ggggcacaag 2100
ctggagtaca actacaacag ccacaacgtc tatatcatgg ccgacaagca gaagaacggc 2160ctggagtaca actacaacag ccacaacgtc tatatcatgg ccgacaagca gaagaacggc 2160
atcaaggtga acttcaagat ccgccacaac atcgaggacg gcagcgtgca gctcgccgac 2220atcaaggtga acttcaagat ccgccacaac atcgaggacg gcagcgtgca gctcgccgac 2220
cactaccagc agaacacccc catcggcgac ggccccgtgc tgctgcccga caaccactac 2280cactaccagc agaacaccccc catcggcgac ggccccgtgc tgctgcccga caaccactac 2280
ctgagcaccc agtccgccct gagcaaagac cccaacgaga agcgcgatca catggtcctg 2340ctgagcaccc agtccgccct gagcaaagac cccaacgaga agcgcgatca catggtcctg 2340
ctggagttcg tgaccgccgc cgggatcact ctcggcatgg acgagctgta caagtaa 2397ctggagttcg tgaccgccgc cgggatcact ctcggcatgg acgagctgta caagtaa 2397
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910012569.2A CN110157721A (en) | 2019-01-07 | 2019-01-07 | A tracer targeting plasmid of vaccinia virus Tiantan strain and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910012569.2A CN110157721A (en) | 2019-01-07 | 2019-01-07 | A tracer targeting plasmid of vaccinia virus Tiantan strain and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110157721A true CN110157721A (en) | 2019-08-23 |
Family
ID=67645307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910012569.2A Pending CN110157721A (en) | 2019-01-07 | 2019-01-07 | A tracer targeting plasmid of vaccinia virus Tiantan strain and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110157721A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109750056A (en) * | 2019-01-07 | 2019-05-14 | 西安医学院 | Targeting plasmid for removing VGF gene of Tiantan strain and preparation method thereof |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102206679A (en) * | 2011-03-30 | 2011-10-05 | 中国人民解放军军事医学科学院军事兽医研究所 | Shuttle vector of vaccinia virus and its application |
US20120276053A1 (en) * | 2005-09-07 | 2012-11-01 | David Kirn | Oncolytic vaccinia virus cancer therapy |
CN105861558A (en) * | 2016-06-24 | 2016-08-17 | 西安医学院 | Vaccinia virus shuttle vector and preparation method and application thereof |
CN107604004A (en) * | 2017-09-22 | 2018-01-19 | 西安医学院 | Tracer target practice plasmid for vaccinia virus Tiantan strain TK genes and preparation method thereof |
US20180119171A1 (en) * | 2014-10-20 | 2018-05-03 | National Center For Aids/Std Control And Prevention, Chinese Center For Disease Control | Replicative vaccinia virus vector hiv vaccine |
CN108676814A (en) * | 2018-04-20 | 2018-10-19 | 西安医学院 | A kind of fluorescent marker shuttle vector of Tiantan strain vaccinia virus and preparation method thereof |
CN109536529A (en) * | 2018-12-10 | 2019-03-29 | 中国医学科学院病原生物学研究所 | A kind of efficient vaccinia virus recombinant carrier and its method for building up |
CN109810953A (en) * | 2019-01-07 | 2019-05-28 | 西安彤盛生物科技有限公司 | The recombination the Temple of Heaven strain oncolytic vaccinia virus of removal TK gene and its preparation and application |
CN110029128A (en) * | 2019-05-06 | 2019-07-19 | 中国医学科学院病原生物学研究所 | It is a kind of it is efficient recombination and screening marker-free vaccinia virus vector and its method for building up |
-
2019
- 2019-01-07 CN CN201910012569.2A patent/CN110157721A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120276053A1 (en) * | 2005-09-07 | 2012-11-01 | David Kirn | Oncolytic vaccinia virus cancer therapy |
CN102206679A (en) * | 2011-03-30 | 2011-10-05 | 中国人民解放军军事医学科学院军事兽医研究所 | Shuttle vector of vaccinia virus and its application |
US20180119171A1 (en) * | 2014-10-20 | 2018-05-03 | National Center For Aids/Std Control And Prevention, Chinese Center For Disease Control | Replicative vaccinia virus vector hiv vaccine |
CN105861558A (en) * | 2016-06-24 | 2016-08-17 | 西安医学院 | Vaccinia virus shuttle vector and preparation method and application thereof |
CN107604004A (en) * | 2017-09-22 | 2018-01-19 | 西安医学院 | Tracer target practice plasmid for vaccinia virus Tiantan strain TK genes and preparation method thereof |
CN108676814A (en) * | 2018-04-20 | 2018-10-19 | 西安医学院 | A kind of fluorescent marker shuttle vector of Tiantan strain vaccinia virus and preparation method thereof |
CN109536529A (en) * | 2018-12-10 | 2019-03-29 | 中国医学科学院病原生物学研究所 | A kind of efficient vaccinia virus recombinant carrier and its method for building up |
CN109810953A (en) * | 2019-01-07 | 2019-05-28 | 西安彤盛生物科技有限公司 | The recombination the Temple of Heaven strain oncolytic vaccinia virus of removal TK gene and its preparation and application |
CN110029128A (en) * | 2019-05-06 | 2019-07-19 | 中国医学科学院病原生物学研究所 | It is a kind of it is efficient recombination and screening marker-free vaccinia virus vector and its method for building up |
Non-Patent Citations (5)
Title |
---|
ORA A. WEISZ等: "Use of recombinant vaccinia virus vectors for cell biology", 《METHODS IN CELL BIOLOGY》 * |
TIANYUE CHEN等: "IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy", 《J IMMUNOTHER CANCER》 * |
张迪: "高效重组且无筛选标记痘苗病毒天坛株载体系统的建立", 《中国优秀硕士学位论文全文数据库基础科学辑》 * |
燕红等: "《微生物资源及利用》", 31 May 2012, 哈尔滨工程大学出版社 * |
盛媛等: "天坛株痘苗病毒基因缺失弱毒株的构建及鉴定", 《中国兽医学报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109750056A (en) * | 2019-01-07 | 2019-05-14 | 西安医学院 | Targeting plasmid for removing VGF gene of Tiantan strain and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108753813B (en) | Methods of obtaining marker-free transgenic plants | |
CN107475267B (en) | 4-hydroxyisoleucine production plasmid and strain and synthesis method of 4-hydroxyisoleucine | |
CN108486105B (en) | Kluyveromyces marxianus promoter as well as preparation method and application thereof | |
CN110540989A (en) | Primer and method for cloning unknown DNA sequence adjacent to known region based on PCR technology | |
CN105176936B (en) | Replicate the subclone and preparation method and application of the Semliki forest virus of tolerance type | |
CN111171132B (en) | Snakehead antibacterial peptide | |
CN111304252B (en) | Method for injecting virus into specific brain region of animal for gene editing based on non-therapeutic purpose of PINK1 and PARK7 | |
CN101693901B (en) | An Escherichia coli-coryneform bacteria shuttle inducible expression vector pDXW-8 and its construction method | |
CN101775410B (en) | Fowlpox virus vector shuttle plasmid and application thereof | |
KR101891603B1 (en) | Recombinant foot-and-mouth disease virus expressing protective antigen of type A, Korean and standard strains | |
CN110734480B (en) | Application of Escherichia coli Molecular Chaperone GroEL/ES in Assisting the Synthesis of Plant Rubisco | |
KR101578444B1 (en) | Recombinant foot-and-mouth disease virus using Korean isolated strain of FMDV A serotype and the manufacturing method | |
CN114317605B (en) | A method for constructing a transgenic mouse model of microglia potassium ion probe | |
CN110157721A (en) | A tracer targeting plasmid of vaccinia virus Tiantan strain and preparation method thereof | |
CN101343636A (en) | Carrier and application for constructing reverse genetic system of influenza virus | |
CN110004131A (en) | A kind of molecular modification method improving lysine decarboxylase activity and stability | |
CN108728484B (en) | Vector for obtaining marker-free transgenic plants and its application | |
CN114438083A (en) | sgRNA for identifying pig PERV gene and coding DNA and application thereof | |
CN113373163B (en) | Codon-optimized Chlamydia trachomatis ctl0286 gene and application thereof | |
CN108410870B (en) | Kluyveromyces marxianus promoter, secretion signal peptide, preparation and application thereof | |
CN102241763A (en) | Continuously activated growth hormone receptor gene of fishes, and preparation method and application thereof | |
CN110747216A (en) | Multigene co-expression complete vector and application thereof | |
CN115109791B (en) | A kind of functional gene delivery vector, construction method and application based on IncQ type plasmid pan-host | |
US20100304461A1 (en) | Portable, Temperature and Chemically Inducible Expression Vector for High Cell Density Expression of Heterologous Genes in Escherichia Coli | |
CN111518833A (en) | Construction method and application of an oncolytic adenovirus carrying AIM2 gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |